 Cambridge Cognition Holdings plc LON:COG, which develops and markets neuroscience technology to assess brain health, announced today its unaudited preliminary results for the year ended 31 December 2019. Highlights 2019 was a year of significant technological and operational advances that provide a solid basis for future profitability, even though transient factors in the pharmaceutical industry adversely affected the ... 